Minerva Imaging welcomed Signe Humle Jorgensen as Head of CRO
Public source
Publisher name
Public post
Welcome Signe Humle Jørgensen to Minerva Imaging! We are thrilled to announce that Signe Humle Jorgensen has joined Minerva Imaging as Head of CRO. Signe is a senior lif…
Company
Minerva Imaging
Accelerated & Efficient Drug Development
- Industry
- Biotechnology Research
- Location
- Ølstykke, DK
- Company size
- 51–200 employees
About Minerva Imaging
Minerva Imaging is a scientifically driven CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
See moreLatest activity
Latest activity from Minerva Imaging
5 signals
Research & Knowledge
Minerva Imaging scholar program student Sarah successfully defended her Master's thesis on heterogeneous responses to radiotherapy and immune checkpoint inhibition across different preclinical tumor models.
Presence & Recognition
Minerva Imaging participated in the 45th edition of the DHL Relay in Copenhagen, which brought together over 160,000 participants from over 2,500 companies.
Strategy & Corporate Development
Minerva Imaging General Manager, US, David Kroon will lead US commercial expansion, build the founding US team, and support strategic evaluation of a future US CDMO footprint.
Discover more
Similar signals
Similar public activity from other companies.
People
TRANSVISTA
TRANSVISTA welcomed Fabio Cacciapaglia, PhD to the team as Senior Sales Manager for North America and Europe.
People
Biotech Research & Innovation Centre (BRIC), University of Copenhagen
Biotech Research & Innovation Centre (BRIC), University of Copenhagen appointed Ferran Fece de la Cruz as the new Group Leader in a joint position between the Finsen Laboratory and BRIC.
People
Tangram Therapeutics
Tangram Therapeutics welcomed Dr. Sonya Montgomery as Chief Development Officer
People
Pictor
Pictor welcomed Christina Rabbani as Operations Manager and Quality Representative.
People
Axol Bioscience Ltd.